Episode
Episode 247 | Stan Glezer, Managing Director at Outcome Capital | Strategic Transactions in MedTech: Insights & Advice
- Podcast
- Project Medtech
- Published
- Feb 2, 2026
- Duration seconds
- 2359
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/project-medtech-601743/episodes/episode-247-stan-glezer-managing-director-at-outcome-capital-strategic-transactions-in-medtech-insights-advice/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/project-medtech-601743/episode-247-stan-glezer-managing-director-at-outcome-capital-strategic-transactions-in-medtech-insights-advice.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Duane Mancini sits down with Stan Glezer, Managing Director at Outcome Capital, to dive deep into the roles of strategic advisory and investment banking in driving innovation within the life sciences sector. Stan elaborates on his multifaceted career, from his beginnings as a physician to leading roles in biopharma and MedTech companies. He discusses the importance of aligning a company's value proposition with market dynamics, the art and science behind M&A deals, and why realistic, transparent goals can unlock transactional success. Stan Glezer LinkedIn Outcome Capital Website Duane Mancini LinkedIn Project Medtech Website Project Medtech LinkedIn Thank you to our sponsors: Ward Law and JumpStart Inc .